Author: Dr. Savatta
-
Radiotherapy and Short-Term Androgen Deprivation for Localized Prostate Cancer — NEJM
Among patients with stage T1b, T1c, T2a, or T2b prostate adenocarcinoma and a PSA level of 20 ng per milliliter or less, the use of short-term ADT for 4 months before and during radiotherapy was associated with significantly decreased disease-specific mortality and increased overall survival. According to post hoc risk analysis, the benefit was mainly…
-
Saint Clare’s Hospital Celebrates Facility Opening – Hopatcong, NJ Patch
Additionally, real-time integrated video and communications systems from Black Diamond Video will place Saint Clare’s in the company of renowned health care organizations with the same technology, such as Cleveland Clinic, Duke, Mass General and Yale, among other select hospitals nationally. via Saint Clare’s Hospital Celebrates Facility Opening – Hopatcong, NJ Patch. I have…
-
Mass. bill would allow videotaping of surgeries – BostonHerald.com
BOSTON – Massachusetts lawmakers are considering a bill that would give patients the right to have their operations videotaped if they pay for it. The measure would let licensed medical videographers tape the procedures. They would not have to be in the operating room at the time. A copy of the surgery would be given…
-
Short-term neoadjuvant androgen deprivation and radiotherapy for locally advanced prostate cancer: 10-year data from the TROG 96.01 randomised trial.
INTERPRETATION: 6 months of neoadjuvant androgen deprivation combined radiotherapy is an effective treatment option for locally advanced prostate cancer, particularly in men without nodal metastases or pre-existing metabolic comorbidities that could be exacerbated by prolonged androgen deprivation. via Short-term neoadjuvant androgen deprivation and radiotherapy for locally advanced prostate cancer: 10-year data from the TROG 96.01…
-
Statins make radiation more effective at curing prostate cancer, study suggests
Statins Make Radiation More Effective at Curing Prostate Cancer, Study Suggests ScienceDaily (Mar. 25, 2011) — Men with high-risk prostate cancer who take statin drugs commonly used to lower cholesterol while receiving radiation therapy are less likely to have their cancer return than patients who do not take these medications, according to a study published…
-
-
Better patient counseling needed on post-RP erectile function – – UrologyTimes
Acting on anecdotal evidence, Dr. Nelson and his co-authors, Peter Scardino, MD, and John P. Mulhall, MD, assessed the erectile function of 250 men average age, 59±8 years pre- and post-radical prostatectomy. Of the men with baseline erectile function scores ≥24 mild to no dysfunction, about one-third 32% regained function; however, well over half 60%…
-
Added Radiation to ADT May Improve Survival – Renal and Urology News
Men with locally advanced prostate cancer (PCa) have a better chance of survival when they add radiation therapy (RT) to their hormone therapy, according to research presented at the 52nd annual meeting of the American Society for Radiation Oncology. via Added Radiation to ADT May Improve Survival – Renal and Urology News. This is another…
-
Dutasteride Slows Prostate Cancer Progression – Renal and Urology News
ORLANDO—Dutasteride, a drug widely prescribed for treating benign prostatic enlargement, lowers the risk of prostate cancer PCa progression in men undergoing active surveillance for the disease, researchers concluded. via Dutasteride Slows Prostate Cancer Progression – Renal and Urology News. Dutasteride has been used for BPH and is thought to help reduce the risk of developing…